WO2024236523 - ONCE DAILY ISOTRETINOIN COMPOSITION
National phase entry is expected:
Publication Number
WO/2024/236523
Publication Date
21.11.2024
International Application No.
PCT/IB2024/054760
International Filing Date
16.05.2024
Title **
[English]
ONCE DAILY ISOTRETINOIN COMPOSITION
[French]
COMPOSITION D'ISOTRÉTINOÏNE QUOTIDIENNE
Applicants **
SUN PHARMACEUTICAL INDUSTRIES LIMITED
Inventors
KIRCIK, Leon
DEL ROSSO, James Q.
Priority Data
63/502,430
16.05.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2330 | |
| EPO | Filing, Examination, Granting | 13969 | |
| Japan | Filing, Examination, Granting | 2533 | |
| South Korea | Filing, Examination, Granting | 2900 | |
| USA | Filing, Examination, Granting | 5740 |
Total:
27,472
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to a method of treating acne comprising administering to the subject, a pharmaceutical composition comprising micronized isotretinoin; wherein, the composition is administered once daily to the subject under a fasting state, at a dose of about 0.4 mg/kg to about 1.6 mg/kg of isotretinoin. In particular, the composition further comprises one or more surfactants; and one or more co-solvents.[French]
La présente invention concerne un procédé de traitement de l'acné comprenant l'administration au sujet d'une composition pharmaceutique comprenant de l'isotrétinoïne micronisée ; la composition étant administrée une fois par jour au sujet dans un état de jeûne, à une dose d'environ 0,4 mg/kg à environ 1,6 mg/kg d'isotrétinoïne. En particulier, la composition comprend en outre un ou plusieurs tensioactifs; et un ou plusieurs co-solvants.